Cipla Company Description
Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally.
The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry.
The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
![Cipla logo](https://img.stockanalysis.com/logos1/NSE/CIPLA.png)
Country | India |
Founded | 1935 |
Industry | Drug Manufacturers - General |
Sector | Healthcare |
Employees | 27,764 |
CEO | Umang Vohra |
Contact Details
Address: Cipla House Mumbai, 400013 India | |
Phone | 91 22 2482 6000 |
Website | cipla.com |
Stock Details
Ticker Symbol | CIPLA |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE059A01026 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Umang Vohra B.E., M.B.A. | MD, Global Chief Executive Officer and Executive Director |
Dr. Raju Sunil Mistry M.A., Ph.D. | President and Global Chief People Officer |
Pradeep Bhadauria | President and Global Chief Scientific Officer |
Ashish Adukia | Global Chief Financial Officer |
Dinesh Ramniranjan Jain | Senior Vice President and Head of Corporate Finance |
Sneha Hiranandani B Com | Chief Information Officer |
Naveen Bansal | Head of Investor Relations |
Rajendra Kumar Chopra | Compliance Officer and Company Secretary |
Heena Kanal | Senior Vice-President of Corporate Communications |
Dr. Jaideep A. Gogtay M.D., Ph.D. | Global Chief Medical Officer |